# Phio Pharmaceuticals Corp.: Form 10-Q for the period ended Sep 30, 2015

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 10-Q
- Filed: 2015-11-12
- Accepted by EDGAR: Nov 12, 2015, 16:05 ET
- Period: 2015-09-30
- Accession: 0001193125-15-375630
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312515375630/d82772d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312515375630/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2015-07-01 to 2015-09-30 | $1.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2015-01-01 to 2015-09-30 | $5.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2015-07-01 to 2015-09-30 | −$2.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2015-01-01 to 2015-09-30 | −$7.6m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2015-07-01 to 2015-09-30 | −$2.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2015-01-01 to 2015-09-30 | −$7.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-07-01 to 2015-09-30 | −$0.04 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2015-01-01 to 2015-09-30 | −$0.18 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2015-01-01 to 2015-09-30 | −$5.7m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2015-01-01 to 2015-09-30 | $39.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2015-09-30 | $4.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-09-30 | $12.5m | us-gaap:AssetsCurrent |
| Total assets | at 2015-09-30 | $12.7m | us-gaap:Assets |
| Current liabilities | at 2015-09-30 | $1.7m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2015-09-30 | $11.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312515375630/d82772d10q.htm

Filed Nov 12, 2015.
Source: SEC EDGAR, the filing index for accession 0001193125-15-375630. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
